Zidovudine
Links shared publicly online about this topic
FDA approves Matrix NDA for Zidovudine Tablets
news-medical.net — “Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief for its New Drug Application for Zidovudine Tablets, 100 mg.” View full resource at news-medical.net
Most Recently Shared on March 11, 2011 at 7:22 am By:
HIV/AIDS News: FDA approves Matrix NDA for Zidovudine Tablets: Mylan Inc. today announced that its subsidiary Ma... http://bit.ly/eG4LYX
RETROVIR CAPSULES (Zidovudine) drug information from MPR
empr.com — “RETROVIR CAPSULES (Zidovudine) drug information for HIV~antivirals from MPR including side effects, drug interactions, dosing, contraindications and precautions.” View full resource at empr.com
Most Recently Shared on April 27, 2009 at 5:09 am By:
MPR News: RETROVIR CAPSULES: Children: dosing updated. http://tinyurl.com/dytumc
New dosing recommendations Retrovir (zidovudine) syrup for HIV-infected infants
fda.gov — “New dosing recommendations Retrovir (zidovudine) syrup for HIV-infected infants” View full resource at fda.gov
Most Recently Shared on November 13, 2009 at 6:56 pm By:
Health Literacy Medical School
FDA Releases New Dosing Recommendations for Zidovudine for HIV-Infected Infants http://ow.ly/BWkn
Is it safe to take creatine with Lamivudine + Zidovudine and efavirenz? - Forum on Nutrition and Exercise
thebody.com — “I am glad you are regaining control of your health after adjusting from the shock of your HIV diagnosis. As you know, we can live long and healthy lives, and many of us become even more motivated...” View full resource at thebody.com
Most Recently Shared on August 11, 2011 at 4:01 pm By:
Ask the HIV/AIDS Experts: "Is It OK to Take Creatine With My HIV Meds?" http://bit.ly/nc3ue9 #supplement
Mylan Garners Approval of Water-Dispersible Zidovudine Tablets - ONA
oncologynurseadvisor.com — “Mylan--™s subsidiary, Matrix Laboratories, announced that under the President's Emergency Plan for AIDS Relief (PEPFAR), the FDA has approved water-dispersible zidovudine tablets, a generic version of Retrovir (GlaxoSmithKline).” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 11, 2011 at 5:00 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Mylan Garners Approval of Water-Dispersible Zidovudine Tablets http://goo.gl/fb/6EITN
Mylan Garners Approval of Water-Dispersible Zidovudine Tablets - MPR
empr.com — “Mylan--™s subsidiary, Matrix Laboratories, announced that under the President's Emergency Plan for AIDS Relief (PEPFAR), the FDA has approved water-dispersible zidovudine tablets, a generic version of Retrovir (GlaxoSmithKline).” View full resource at empr.com
Most Recently Shared on March 11, 2011 at 5:02 pm By:
MPR News: Mylan Garners Approval of Water-Dispersible Zidovudine Tablets: Mylan's subsidiary, Matrix Laboratorie... http://bit.ly/eYkQTV
FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA
news-medical.net — “Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine and Zidovudine Tablets, 30 mg/60 mg.” View full resource at news-medical.net
Most Recently Shared on January 20, 2011 at 2:21 pm By:
HIV/AIDS News: FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA: Mylan In... http://bit.ly/dXASt0
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Lamivudine And Zidovudine Tablets, 30 Mg/60 Mg
medicalnewstoday.com — “Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency” View full resource at medicalnewstoday.com
Most Recently Shared on January 21, 2011 at 5:05 pm By:
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Lamivudine And Zidovudine Tablets, 30 Mg/60 Mg http://mnt.to/3QhS #hivaids
Approval of Generic Formulation of Lamivudine and Zidovudine Tablets, 150 mg/300 mg - The Body
thebody.com — “On May 25, 2011, FDA granted approval for a generic formulation fixed dose combination of lamivudine and zidovudine tablets, 150 mg/300 mg, a two ...” View full resource at thebody.com
Most Recently Shared on May 27, 2011 at 10:01 pm By:
Approval of Generic Formulation of Lamivudine and Zidovudine Tablets, 150 mg/300 mg http://bit.ly/jloNoa #hiv #aids #combivir
Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovud... http://bit.ly/hleyNz
onlinelibrary.wiley.com — “Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovud... http://bit.ly/hleyNz” View full resource at onlinelibrary.wiley.com
Most Recently Shared on January 26, 2011 at 12:50 am By:
Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovud... http://bit.ly/hleyNz
Mylan Inc. - Mylan's Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg
investor.mylan.com — “Mylan Inc. - Mylan's Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg” View full resource at investor.mylan.com
Most Recently Shared on March 10, 2011 at 3:42 pm By:
eyeonfda Pharma and Health Lawyer
Mylan's Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg - http://ow.ly/4bIzA
Addition of zidovudine prophylaxis to nevirapine may reduce nevirapine-resistance in postnatal infection
pediatricsupersite.com — “Supplementing extended nevirapine prophylaxis with zidovudine significantly reduced the risk of nevirapine resistance at 14 weeks in infants who” View full resource at pediatricsupersite.com
Most Recently Shared on February 23, 2010 at 2:42 pm By:
Pediatric SuperSite Health Site
From #CROI, Addition of #zidovudine prophylaxis to #nevirapine may reduce nevirapine-resistance in postnatal infection: http://ow.ly/1ajUN
IngentaConnect Efavirenz/lamivudine/zidovudine: Immune reconstitution syndrome i...
ingentaconnect.com — “IngentaConnect Efavirenz/lamivudine/zidovudine: Immune reconstitution syndrome i...” View full resource at ingentaconnect.com
Most Recently Shared on July 4, 2010 at 8:32 am By:
Efavirenz/lamivudine/zidovudine: Immune reconstitution syndrome in an HIV-positive patient with tuberculosis: case... http://bit.ly/aHUipj
Reducing the Spread of HIV from Mothers to Infants
hcplive.com — “Adding drugs to the standard zidovudine treatment given to infants born to HIV-positive women can reduce the chances that the child will develop the infection.” View full resource at hcplive.com
Most Recently Shared on March 10, 2011 at 3:23 pm By:
Reducing the Spread of HIV from Mothers to Infants http://hcp.lv/gPW7DI
Allergy/Imm Medical News about HIV
mdlinx.com — “International Cohort Analysis of the Antiviral Activities of Zidovudine and Tenofovir in the Presence of the K65R Mutation in Reverse Transcriptase” View full resource at mdlinx.com
Most Recently Shared on March 25, 2010 at 12:04 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
International Cohort Analysis of the Antiviral Activities of Zidovudine and Tenofovir in the Presence o... http://bit.ly/ab6XcS #AI #mdlinx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest HIV/AIDS news and research via News-Medical.Net
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Health Literacy
Information on Health Literacy and Public Health
Advertisement
